Oncocyte Corporation - Common Shares, No Par Value (OCX)

Q2 2019 13F Holders as of 6/30/2019

Type / Class
Equity / Common Shares, No Par Value
Number of holders
46
Total Shares
16M
Shares change
-138K
Total reported value, excl. options
$39.7M
Value change
-$2.95M
Number of buys
29
Number of sells
-25
Price
$2.49
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.